ライフサイエンスコーパス: noncoronary

1 for other cardiac surgery (28%), unsuitable noncoronary anatomy (13%), coronary obstruction (11%), a

2 sociated with an increased odds of prevalent noncoronary and generalized atherosclerosis independentl

3 he deformation modes of the left, right, and noncoronary aortic root regions during isovolumic contra

4 rity of patients from either the left or the noncoronary aortic sinus of Valsalva.

5 juxtacommissural origin between the left and noncoronary aortic sinus.

6 The authors also focus on noncoronary applications involving the expanding role of

7 FMD must be identified in at least one other noncoronary arterial territory to attribute any coronary

8 ntimal hyperplasia after balloon dilation of noncoronary arteries in small-animal models, suggesting

9 During follow-up (median: 502 days), noncoronary artery bypass graft (CABG) bleeding occurred

10 roportions for the primary outcome (death or noncoronary artery bypass graft protocol major bleeding

11 The primary outcome was the rate of noncoronary artery bypass graft related thrombolysis in

12 tor of ischemic and bleeding events although noncoronary artery bypass graft related Thrombolysis in

13 Only, noncoronary artery bypass graft related Thrombolysis in

14 coronary artery bypass graft surgery, single noncoronary artery bypass graft surgery, two procedures,

15 es]), the association between post-discharge noncoronary artery bypass graft-related GUSTO (Global Us

16 In these, the IRA or a new noncoronary artery disease diagnosis was identified by D

17 y coronary angiography, a different IRA or a noncoronary artery disease diagnosis was identified by D

18 nal diagnosis in 127 patients (15%); cardiac noncoronary artery disease, in 124 (14%).

19 mug/L]; P<0.001) than patients with cardiac noncoronary artery disease.

20 ocardial infarction (AMI) from acute cardiac noncoronary artery disease.

21 ted patients with AMI and those with cardiac noncoronary artery disease.

22 een patients with AMI and those with cardiac noncoronary artery disease.

23 mong younger patients, women, and those with noncoronary ASCVD.

24 mg/dl showed an association with subclinical noncoronary atherosclerosis (odds ratio [OR]: 1.35; 95%

25 mputed tomography were performed to quantify noncoronary atherosclerosis and coronary calcification.

26 cute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major ad

27 Noncoronary cardiac abnormalities are associated with co

28 We explored the association of noncoronary cardiac abnormalities with coronary artery d

29 bypass surgery and in patients who also had noncoronary cardiac disease.

30 vascularization and over half diagnosed with noncoronary cardiac etiologies.

31 ntly available or under development to guide noncoronary cardiac interventional procedures, and sugge

32 ment of improved imaging techniques to guide noncoronary cardiac interventions.

33 This review provides an overview of the noncoronary cardiac structures that can be evaluated wit

34 y, in fact, identify a potentially treatable noncoronary cause for chest pain.

35 and esophagitis, is a potentially treatable noncoronary cause for chest pain.

36 ediction model that accounts for deaths from noncoronary causes among older adults provided well-cali

37 Deaths from noncoronary causes largely exceeded the number of CHD ev

38 low probability of CAD focuses on diagnosing noncoronary causes of chest pain.

39 rdial infarction compared with patients with noncoronary CP.

40 In patients with AS, the noncoronary cusp (NCC) carried the greatest AVLC(CTA) (3

41 right coronary cusp (RCC) in 14 (31.8%), the noncoronary cusp (NCC) in 1 (2.3%), and at the junction

42 ting patterns were observed in the right and noncoronary cusp fusion patients.

43 Right and noncoronary cusp fusion, increasing AS and AI, and older

44 Mean implantation depth under the noncoronary cusp was significantly smaller with HDT comp

45 n of a left coronary artery (right cusp, 13; noncoronary cusp, one).

46 stenotic) and 3 with fusion of the right and noncoronary cusp.

47 Clinically important noncoronary diagnoses that did not explain patient sympt

48 ACS patients presenting to the ED provided a noncoronary diagnosis that explained the presenting comp

49 group 2 had late gadolinium enhancement in a noncoronary distribution, and no subjects in groups 3 an

50 l but also midmyocardial and transmural with noncoronary distributions.

51 The inclusion of noncoronary end points in this tool expands the range of

52 d differential patterns with coronary versus noncoronary events.

53 terior flow jets (n = 11), whereas right and noncoronary fusion gave rise to left-handed helical flow

54 ivation is a common feature in patients with noncoronary heart disease with a history of VF, and its

55 fractionation analysis in 266 patients with noncoronary heart disease.

56 undergoing invasive coronary angiography for noncoronary indications.

57 organ failure is a leading cause of death in noncoronary intensive care units.

58 milar density of innervation, except for the noncoronary leaflet of the aortic valve in which the inn

59 ostic relevance, as the fusion of right- and noncoronary leaflets (R-N) is associated with a greater

60 Coronary SMCs, however, were distinct from noncoronary medial cells, which displayed greater phenot

61 l operation in which a portion of the aortic noncoronary (n = 3) or right coronary (n = 3) leaflet wa

62 t was associated with a higher prevalence of noncoronary (odds ratio: 1.55; 95% confidence interval:

63 aggregation and inflammation in coronary and noncoronary patients.

64 , 4 [2.0% {95% CI, 0.8%-5.1%}] left coronary-noncoronary raphe), and type 2 in 1 (0.5% [95% CI, 0.1%-

65 [13.8% {95% CI, 9.6%-19.3%}] right coronary-noncoronary raphe, 4 [2.0% {95% CI, 0.8%-5.1%}] left cor

66 e not homogeneous among the left, right, and noncoronary regions.

67 fusion patterns (right-left, RL versus right-noncoronary, RN) and expression of aortopathy.

68 us had rS pattern in lead I, and VT from the noncoronary sinus had a notched R wave in lead I.

69 ences in integrin expression on coronary and noncoronary SMCs may account for cellular differences.

70 ion on freshly isolated porcine coronary and noncoronary SMCs revealed that coronary SMCs express sig

71 d smooth muscle myosin heavy chain), whereas noncoronary SMCs showed marked phenotypic heterogeneity.

72 and to compare the responses of coronary and noncoronary SMCs to stimulation.

73 SMCs (human and porcine) were distinct from noncoronary SMCs, showing poor adhesion and spreading, a

74 ress significantly less alpha(5)beta(1) than noncoronary SMCs, whereas the expression of total beta(1

75 onary smooth muscle cells (SMCs) differ from noncoronary SMCs.

76 n of coronary SMCs to the levels observed in noncoronary SMCs.

77 utside the pre-defined period, or involved a noncoronary stent.

78 detector CT can be used to evaluate numerous noncoronary structures in the same examination.

79 ted a higher prevalence of multiple affected noncoronary territories (odds ratio: 1.34; 95% confidenc

80 This study investigated noncoronary vascular calcification and its influence on

81 Relatively little is known about noncoronary vascular calcification.

82 in therapy is beneficial among patients with noncoronary vascular disease (such as congestive heart f

83 Noncoronary vascular disease and clinically important va